Cervix Lesion
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions (NCT05625308) | Lo.Li.Pharma s.r.l | 2022-07-01 |
| Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance (NCT04624568) | Centre Hospitalier Régional d'Orléans | 2020-11-17 |
| Multimodality Treatments of HPV-related Lesions of the Female Genital Tract (NCT05938192) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-07-15 |
| Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN. (NCT04171505) | Hospital San Carlos, Madrid | 2019-11-04 |
| Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. (NCT04199078) | Procare Health Iberia S.L. | 2019-09-25 |
| Honduras Liger Thermocoagulator Study (NCT03510273) | PATH | 2018-05-04 |
Track Cervix Lesion automatically
Every clearance here is in the API, with alerts when new ones post.